Locations:
Search
Prior history of autoimmunity and solid organ transplantation significantly increases chance of myelodysplastic syndrome or acute myeloid leukemia
Distinct molecular features found in five subtypes of disease
Patients who relapse early after first-line chemotherapy are often, but not always, refractory to second-line chemotherapy
Elevated levels of vWF and FVIII associated with risk of blood clots, severe COVID-19 and death
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Study matches momelotinib against danazol
Majority of patients achieve complete pathologic response after four-dose cemiplimab therapy
Pilot Study at Cleveland Clinic is Testing Feasibility and Biodistribution
Pathogenic POLE/POLD1 mutations lead to improved response to immune checkpoint blockade therapy
Blinatumomab followed by POMP maintenance shows effectiveness for newly diagnosed patients
Study to test efficacy of immunotherapy with chemotherapy and radiation
Advertisement
Advertisement